Know why hospitals, nursing homes, and DMEPOS suppliers are in the limelight.
Quality reporting and your handling of inpatient care are on the OIG’s radar for 2016, so prepping now to cover any compliance gaps in these and some other key areas will be crucial.
On Nov. 2, the HHS Office of Inspector General (OIG) published its Fiscal Year (FY) 2016 Work Plan. Read on for what you can expect from OIG reviews in the coming year.
Hospital Quality Reporting Goes Under the Microscope
The OIG has several new initiatives for hospitals in 2016. To begin with:
Way to go: Proactively collect data on patient care outcomes and safety events in your hospital and identify performance trends. LTCHs will want to implement any changes proposed in these reports in the years to come to avoid preventable harm.
You could follow the already existing Joint Commission’s safety standards which require that at least every 18 months, the hospital should select one high risk process and conduct a proactive risk assessment.
Orthotic Braces and Ventilators Become a ‘Prime Target’
One new OIG focus is the feasibility of orthotic brace costs by comparing the Medicare fee schedule amounts with non-Medicare payer reimbursement. What’s more, get ready for a new investigation into osteogenesis stimulators, or “bone-growth stimulators,” to determine whether renting the devices instead of purchasing could save money for Medicare and beneficiaries.
Medical necessity: The OIG plans to crack down on Medicare Part B payments for orthotic braces to determine whether durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) suppliers’ claims were medically necessary. Prior reviews revealed that some DMEPOS suppliers billed for services that were medically unnecessary.
Watch your ventilator bills: That’s not all. The OIG also will launch a new investigation into billing trends for ventilators, respiratory assist devices (RAD), and continuous positive airway pressure (CPAP) devices from 2011 to 2014. This stems from a significant increase in billing for ventilators, especially for pressure support ventilators.
Anticipate Scrutiny of 340B Program
Although not a new effort, the OIG is looking into prescription drugs under the 340B program, to find ways to cut on Medicare costs through 340B discounts.
The issue: As of now, eligible healthcare providers can purchase prescription drugs at discounted prices under the 340B program. Then these providers bill Medicare and other insurers for the full price of the drug, piling on the drug cost to payers unreasonably.
Additionally, the OIG will now move the dial on inappropriate drug pairs under Medicare Part D. These are drugs that should not be prescribed along with other drugs due to the possibility of drug interactions and undesirable side effects.
Prepare for a Variety of New Provider Inquiries
The OIG wants to determine whether CMS made payments correctly for services, supplies, and DME, specifically reviewing whether those physicians and NPPs are in fact Medicare-enrolled and legally eligible to refer/order.
So, brace yourself for new reviews of Medicare services, supplies, and DME that physicians and non-physician practitioners (NPPs) refer or order for patients.
Pay attention: OIG will also review Medicare Part B claims for anesthesia services to find out whether the claims were valid and the beneficiary had a related Medicare service. Likewise, the OIG will be examining the adequacy of Medicare payments to physicians for evaluation and management (E/M) home visits and prolonged E/M services.
Show OIG Your ICD-10 Success
The Work Plan includes taking stock of CMS’s management of ICD-10 implementation as well. The OIG may review CMS’s and its contractors’ assistance and guidance to hospitals and physicians, as well as assess how the ICD-10 transition is affecting claims processing, including claims resubmissions, appeals, and medical reviews. This looks like OIG is trying to take stock of the situation post ICD-10.
“I think the OIG wants to look at the overall process and then determine if there are any problem areas,” contemplates Duane C. Abbey, PhD, president of Abbey and Abbey Consultants Inc., in Ames, IA.
Final takeaway: The OIG’s Work Plan gives you a good idea of targeted areas to devise your 2016 strategy. The OIG is continuously investigating in multiple ways, such as analyzing your Medicare and Medicaid payment data amongst other things. So, be careful about not just fraud and abuse, but also waste that could be prevented. Be proactive and remember that waste might easily become overpayments and could snowball into potential False Claims Act and Stark Law violations.
“Unfortunately, healthcare providers do not have unlimited resources when it comes to addressing all potential compliance issues,” reflects Abbey. Therefore, “hospitals and other healthcare providers need to prioritize these OIG identified issues along with other compliance issues facing the given healthcare provider.”
Link: To view the entire FY 2016 OIG Work Plan, go to http://oig.hhs.gov/reports-and-publications/archives/workplan/2016/oig-work-plan-2016.pdf.